We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
-16.57%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$2.32B
AUM Growth
-$327M
Cap. Flow
+$342M
Cap. Flow %
14.73%
Top 10 Hldgs %
50.61%
Holding
68
New
7
Increased
38
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$48.2M
2
ZBH icon
Zimmer Biomet
ZBH
+$31.6M
3
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$31.4M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$31.1M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$30.5M

Top Sells

Rank Stock Value
1
ACHN
Achillion Pharmaceuticals
ACHN
+$44.1M
2
ARVN icon
Arvinas
ARVN
+$15.2M
3
A icon
Agilent Technologies
A
+$12.8M
4
PODD icon
Insulet
PODD
+$11.6M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$8.74M

Sector Composition

Rank Sector Weight
1 Healthcare 94.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTA icon
26
Establishment Labs
ESTA
$2.28B
$33.5M 1.44%
2,319,138
+286,692
+14% +$6.33M
AGEN
27
Agenus
AGEN
$290M
$32.1M 1.38%
667,273
+215,021
+48% +$13.5M
WVE icon
28
Wave Life Sciences
WVE
$1.2B
$31.8M 1.37%
3,389,933
+1,684,459
+99% +$14.4M
DMTK
29
DELISTED
DermTech, Inc. Common Stock
DMTK
$29.1M 1.25%
2,600,729
+213,858
+9% +$2.63M
TNDM icon
30
Tandem Diabetes Care
TNDM
$1.56B
$28.6M 1.23%
+443,725
New +$31.1M
PRQR icon
31
ProQR Therapeutics
PRQR
$265M
$26.2M 1.13%
4,779,135
– –
NSTG
32
DELISTED
NanoString Technologies, Inc.
NSTG
$25.5M 1.1%
1,059,621
+480,689
+83% +$13.9M
STAA icon
33
STAAR Surgical
STAA
$1.21B
$21.8M 0.94%
675,650
+373,439
+124% +$12.6M
CSTL icon
34
Castle Biosciences
CSTL
$979M
$20.8M 0.9%
698,118
+67,046
+11% +$2.02M
XGN icon
35
Exagen
XGN
$166M
$20M 0.86%
1,255,640
+536,694
+75% +$10.7M
PTGX icon
36
Protagonist Therapeutics
PTGX
$9.44B
$18.8M 0.81%
2,660,392
+200,404
+8% +$1.5M
JNJ icon
37
Johnson & Johnson
JNJ
$625B
$15.3M 0.66%
116,858
– –
ARVN icon
38
Arvinas
ARVN
$572M
$13.9M 0.6%
344,937
-325,358
-49% -$15.2M
APYX icon
39
Apyx Medical
APYX
$171M
$12.2M 0.52%
3,391,279
– –
TXG icon
40
10x Genomics
TXG
$6.61B
$11.8M 0.51%
190,109
+185,109
+3,702% +$14.4M
RGNX icon
41
Regenxbio
RGNX
$708M
$10.2M 0.44%
313,606
+7,995
+3% +$333K
ODT
42
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$10.1M 0.44%
366,085
+9,333
+3% +$272K
LJPC
43
DELISTED
La Jolla Pharmaceutical Company
LJPC
$9.89M 0.43%
2,354,734
+66,743
+3% +$422K
MDXG icon
44
MiMedx Group
MDXG
$633M
$9.42M 0.41%
2,700,320
-2,219
-0.1% -$7.74K
TELA icon
45
TELA Bio
TELA
$38.9M
$8.91M 0.38%
1,139,358
– –
BWAY
46
Brainsway
BWAY
$622M
$8.79M 0.38%
2,214,840
+297,988
+16% +$1.5M
CTMX icon
47
CytomX Therapeutics
CTMX
$754M
$8.18M 0.35%
1,066,791
+27,198
+3% +$190K
MIST icon
48
Milestone Pharmaceuticals
MIST
$152M
$7.94M 0.34%
4,315,102
+356,838
+9% +$6.18M
QURE icon
49
uniQure
QURE
$3.22B
$7.41M 0.32%
156,076
+3,980
+3% +$229K
ABUS icon
50
Arbutus Biopharma
ABUS
$915M
$6.94M 0.3%
6,869,281
+1,202,527
+21% +$3.25M
1
2
3

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

RTW Investments's Q1 2020 Portfolio in Review

As of Q1 2020, RTW Investments held 68 positions worth $2.32B, down 12% from $2.65B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

RTW Investments deployed $342M of net new capital in Q1 2020, opening 7 new positions and adding to 38 existing holdings. Its largest new stake was Global Blood Therapeutics, Inc.: 719,489 shares worth $36.8M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier.

On the sell side, the largest reduction was Arvinas, an estimated $15.2M trimmed.

  • RTW Investments's largest Q1 2020 buy was Global Blood Therapeutics, Inc.: 719,489 shares worth $36.8M.
  • RTW Investments added most to Zimmer Biomet in Q1 2020, an estimated $31.6M increase.
  • RTW Investments's biggest Q1 2020 reduction was Arvinas, cutting an estimated $15.2M.
  • RTW Investments fully exited Achillion Pharmaceuticals in Q1 2020, selling an estimated $44.1M.
  • RTW Investments's ten largest holdings make up 51% of its $2.32B portfolio in Q1 2020.
  • RTW Investments opened 7 new positions and closed 3 in Q1 2020.
  • RTW Investments's portfolio value fell 12% quarter-over-quarter to $2.32B.

Based on RTW Investments's 13F filing for Q1 2020, filed 15 May 2020.